TrialMedical oncology (Northwood, London, England)2013
S-1 plus CIK as second-line treatment for advanced pancreatic cancer.
Meng Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it
TrialMedical oncology (Northwood, London, England)2013
Meng Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.